R 0008/13 of 15.09.2015

European Case Law Identifier: ECLI:EP:BA:2015:R000813.20150915
Date of decision: 15 September 2015
Case number: R 0008/13
Online on: 4 March 2016
Petition for review of: -
Application number: 96102992.3
IPC class: A61P 25/04 A61K 9/20 A61K 31/485
Language of proceedings: English
Distribution: Distributed to board chairmen and members (B)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: R 0008/13 2015-03-20
Abstracts for this decision: -
Application title: Controlled release oxycodone compositions
Applicant name: The Purdue Pharma Company
Mundipharma GmbH
Napp Pharmaceutical Holdings Limited
Norpharma A/S
Mundipharma Pharmaceuticals S.R.L.
Mundipharma Laboratories GmbH
Mundipharma Pharmaceuticals BV
Mundipharma AB
Mundipharma AG
Mundipharma Farmaceutica LDA
Mundipharma Pharmaceuticals SL
Mundipharma GesmbH
Mundipharma CVA
Opponent name: Lannacher Heilmittel Ges.m.b.H.
Board: EBA
Headnote: -
Relevant legal provisions: European Patent Convention Art 112a European Patent Convention R 104
Keywords: Violations of the right to be heard: no. Other procedural defects: no
Petition not allowable
Catchword: -
Cited cases: G 0006/95 G 0002/10 R 0001/08 R 0013/09 R 0016/10 R 0019/11 R 0015/12 R 0016/13
Citing cases: R 0019/12 R 0003/15 R 0004/16 R 0006/16 R 0008/17 R 0006/18 R 0005/19 R 0008/19 R 0009/20 R 0006/21 R 0024/22 R 0003/23 R 0004/23 R 0010/23 R 0016/23 R 0017/23 R 0004/24 R 0013/24 R 0014/24 R 0017/24 R 0002/25 J 0006/22 T 1627/09 T 1257/14 T 1787/16 T 2078/17 T 1874/23

ORDER

For these reasons it is decided that:

The petition for review is rejected as unallowable.